Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine Release Machinery at the Neuromuscular Junction (ACh Release Machinery at NMJ)
- Target
- ACh Release Machinery at NMJ
- Molecular classification
- Protein Complex, Synaptic Vesicle Fusion Machinery, Calcium Signaling Pathway Component
01
Overview
The acetylcholine (ACh) release machinery at the neuromuscular junction (NMJ) refers to the complex set of molecular components and processes responsible for the regulated exocytosis of ACh from motor neuron terminals into the synaptic cleft. This machinery enables communication between nerve and muscle fibers, ultimately triggering muscle contraction. Key components include synaptic vesicles, voltage-gated calcium channels, SNARE proteins, acetylcholinesterase, and nicotinic acetylcholine receptors. The process involves action potential arrival, calcium influx, vesicle fusion, ACh release, receptor activation, and signal termination. Disruption or dysfunction in any component can lead to neuromuscular disorders.
- Other names
- Neuromuscular Junction Transmission MachineryPresynaptic Acetylcholine Release ComplexNMJ Exocytosis Machinery
02
Mechanism of action
Regulated exocytosis of acetylcholine into the synaptic cleft, triggered by calcium influx and mediated by SNARE proteins.
03
Biological functions
Neurotransmitter ReleaseSynaptic TransmissionMuscle Contraction InitiationVesicle TraffickingCalcium-dependent Exocytosis
04
Disease associations
Myasthenia Gravis (indirectly)Lambert-Eaton Syndrome (indirectly)Botulism (indirectly)Neuromuscular Disorders
05
Safety considerations
Dysfunction can lead to paralysis or muscle weakness.Target of potent toxins (e.g., botulinum toxin).
06
Interacting drugs
Botulinum Toxin
3 more in the full profile.
Beyond the preview
Go deeper on Acetylcholine Release Machinery at the Neuromuscular Junction (ACh Release Machinery at NMJ).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acetylcholine Release Machinery at the Neuromuscular Junction (ACh Release Machinery at NMJ).